Felix Lee Kar Chung is an executive director of UMP Healthcare Holdings (722:HK) and the president of UMP Healthcare China Limited. He is responsible for corporate development, international operations, merger and acquisitions, and is also in charge of UMP’s China operations. He is also a senior vice president of Chow Tai Fook Enterprises Limited, with responsibilities in making investments in both the healthcare sector in Asia and globally. Mr Lee is also an independent non-executive director of China Resources Medical (1515:HK). Mr Lee has extensive experience in law, finance, and the healthcare industry. Prior to his current roles, he was a solicitor at Freshfields Bruckhaus Deringer, an analyst in the investment banking department for UBS AG, Hong Kong Branch, and a director in the investment banking department of Deutsche Bank AG, Hong Kong Branch.
Mr Lee obtained a Bachelor of Laws from the London School of Economics and Political Sciences. He has been a solicitor of the High Court of Hong Kong since 2007. Mr Lee is also a member of the China Committee and the Greater Bay Area Committee, the Hong Kong General Chamber of Commerce.